1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seagen Inc.
  6. Calendar
    SGEN   US81181C1045

SEAGEN INC.

(SGEN)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
180.11 USD   +1.79%
07/02Seagen Announces Results from Pivotal MOUNTAINEER Trial Demonstrating Clinically Meaningful Antitumor Activity of TUKYSA« (tucatinib) in Combination with Trastuzumab in Previously Treated HER2-Positive Metastatic Colorectal Cancer
BU
07/02Seagen Inc. Announces Full Results from the Pivotal Phase 2 MOUNTAINEER Trial, Which Showed TUKYSA in Combination with Trastuzumab
CI
07/01INSIDER SELL : Seagen
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart SEAGEN INC.
Upcoming events on SEAGEN INC.
07/28/22 Interim 2022 Earnings Release (Projected)
10/27/22 Q3 2022 Earnings Release (Projected)
02/09/23 FY 2022 Earnings Release (Projected)
04/27/23 Q1 2023 Earnings Release (Projected)
Past events on SEAGEN INC.
06/10/22 | 05:30am European Hematology Association Meeting
06/06/22 | 04:00pm American society of clinical oncology meeting - abstract number: 0000
06/06/22 | 02:15pm American society of clinical oncology meeting - abstract number: ps6100
06/06/22 | 11:12am American society of clinical oncology meeting - abstract number: 507
06/06/22 | 09:00am American society of clinical oncology meeting - abstract number: ps1127
06/06/22 | 09:00am American society of clinical oncology meeting - abstract number: ps1111
06/06/22 | 09:00am American society of clinical oncology meeting - abstract number: ps1108
06/05/22 | 09:00am American society of clinical oncology meeting - abstract number: ps3159
06/05/22 | 09:00am American society of clinical oncology meeting - abstract number: ps3154
06/05/22 | 09:00am American society of clinical oncology meeting - abstract number: ps3155
Past dividends on SEAGEN INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
482
482
0,00%
655
644
1,7%
917
846
8,4%
2 176
2 160
0,71%
1 574
1 546
1,8%
 
1 787
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-172
-199
14%
-234
-212
-10%
-197
-246
20%
649
587
11%
-616
-605
-1,8%
 
-557
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-196
-215
9,1%
-260
-237
-9,7%
-221
-266
17%
597
587
1,7%
-682
-665
-2,5%
 
-657
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-159
-128
-24%
-246
-170
-45%
-159
-261
39%
616
608
1,3%
-676
-650
-3,9%
 
-658
 
Net income
M $
Released
Forecast
Spread
-126
-129
3,0%
-223
-172
-29%
-159
-262
39%
614
597
2,7%
-674
-639
-5,6%
 
-653
 
EPS
$
Released
Forecast
Spread
-0,88
-0,90
2,3%
-1,41
-1,11
-27%
-0,96
-1,59
40%
3,37
3,31
1,9%
-3,70
-3,50
-5,7%
 
-3,45
 
Announcement Date02/06/201802/07/201902/06/202002/11/202102/09/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread
332
336
-1,2%
388
358
8,7%
424
385
10%
430
402
7,0%
426
403
5,9%
 
438
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-106
-114
6,7%
-79,6
-107
26%
-287
-93,0
-209%
-154
-112
-37%
-116
-160
28%
 
-116
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-122
-114
-7,1%
-89,6
-113
21%
-298
-107
-179%
-172
-162
-6,5%
-133
-187
29%
 
-159
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-121
-109
-12%
-84,6
-110
23%
-293
-102
-187%
-177
-158
-12%
-135
-180
25%
 
-160
 
Net income
M $
Released
Forecast
Spread
-121
-109
-12%
-84,6
-109
22%
-294
-103
-185%
-175
-156
-12%
-136
-182
25%
 
-157
 
EPS
$
Released
Forecast
Spread
-0,67
-0,61
-9,1%
-0,47
-0,60
22%
-1,61
-0,57
-181%
-0,95
-0,84
-13%
-0,74
-1,00
26%
 
-0,84
 
Announcement Date04/29/202107/29/202110/28/202102/09/202204/28/2022-
Previous year Next Year
Upcoming sector events for SEAGEN INC.
More events
Past sector events for SEAGEN INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise